Blog

Placental-Derived Stem Cell Therapy for Premature Babies with Intestinal Disease

Premature babies have a very difficult start to life. Their bodies are not adequately prepared for life outside of the womb and they are vulnerable to a range of illnesses.

One of the most common illnesses suffered by premature babies is called necrotising enterocolitis. It is a life-threatening disease of the bowels, which affects about 10% of all pre-term babies.

Read More

Umbilical Cord Stem Cells Hold Potential in Pulmonary Fibrosis Treatment

Pulmonary Fibrosis is a potentially life-threatening condition caused by scarring of the lungs. It leads to a variety of dangerous complications including lung cancer, pulmonary hypertensions, pneumothorax, and respiratory failure.

A new study suggests that pulmonary fibrosis could be treated with umbilical cord stem cells. The study, titled “Extracellular vesicles derived from umbilical cord mesenchymal stromal cells alleviate pulmonary fibrosis by means of transforming growth factor-β signaling inhibition” was recently published in Stem Cell Research & Therapy.

Read More

Using Cord Blood MSCs to treat BPD in Premature Infants Shows Promising Results

The results of a Phase II clinical trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) have recently been published.

Bronchopulmonary dysplasia is a lung disease which affects newborn babies. It is particularly common in premature infants and babies with a low birth weight. Researchers believe that the condition is exacerbated by or caused by prolonged mechanical ventilation.

Read More

Recent Posts